Where can Singapore take the lead in alternative proteins?
Tessa Oh
SINGAPORE is investing heavily in alternative proteins in a bid to become a world leader – but its status as a global hub, especially for manufacturing, may be threatened as other countries catch up.
Alternative proteins do not involve the slaughter of animals; they may be plant-based, fermented using microbes, or cultivated from animal cells.
In Singapore, investments in such proteins multiplied to US$169.8 million by 2022, from just US$5.9 million in 2019, according to think tank Good Food Institute (GFI). This was part of the US$562 million Asia-Pacific total in 2022, up from US$42 million in 2019.
TRENDING NOW
Abandoned ‘Titanic’, failing ‘ancient towns’: Why China’s tourism boom leaves white elephants behind
Private equity giant Carlyle can grow bigger but needs to stay on its toes: co-founder David Rubenstein
Singapore to establish over-the-counter gold clearing system, central bank vaulting by end-2026
Singapore public sector commands highest AI salary premium as job postings surge: PwC study